← Cigna Group
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $39.8b |
$41.8b
+4.94%
|
$48.6b
+16.37%
|
$153.6b
+215.65%
|
$160.4b
+4.45%
|
$174.1b
+8.53%
|
$180.5b
+3.70%
|
$195.3b
+8.17%
|
$247.1b
+26.56%
|
$274.9b
+11.24%
|
$259.4b
-5.63%
|
|
| Cost of Revenue | $36.8b |
$2.5b
-93.32%
|
$4.8b
+95.15%
|
$97.7b
+1937.72%
|
$103.5b
+5.95%
|
$117.6b
+13.60%
|
$124.8b
+6.19%
|
$133.8b
+7.18%
|
$182.5b
+36.40%
|
$215.0b
+17.80%
|
$256.6b
+19.35%
|
|
| Gross Profit (Calculated) | $3.1b |
$39.4b
+1174.29%
|
$43.9b
+11.45%
|
$55.9b
+27.46%
|
$56.9b
+1.82%
|
$56.5b
-0.69%
|
$55.7b
-1.49%
|
$61.5b
+10.38%
|
$64.6b
+5.12%
|
$59.9b
-7.28%
|
— | |
| Selling, General and Administrative Expense | $9.8b | $10.0b | $11.9b | $14.1b | $14.1b | $13.0b | $13.2b | $14.8b | $14.8b | $14.6b | $15.1b | |
| Amortization of Intangible Assets | $151.0m | $115.0m | $235.0m | $2.9b | $2.0b | $2.0b | $1.9b | $1.8b | $1.7b | $1.7b | — | |
| Amortization of acquired intangible assets | $151.0m | $115.0m | $235.0m | $2.9b | $2.0b | $2.0b | $1.9b | $1.8b | $1.7b | $1.7b | — | |
| Operating Income (Loss) | $3.1b |
$3.9b
+27.66%
|
$4.2b
+5.53%
|
$8.1b
+94.16%
|
$8.2b
+0.94%
|
$7.9b
-2.67%
|
$8.4b
+6.04%
|
$8.5b
+1.45%
|
$9.4b
+10.32%
|
$9.2b
-2.30%
|
$8.9b
-3.14%
|
|
| Interest Expense, Debt | — | $243.0m | $507.0m | $1.6b | $1.4b | $1.3b | $1.3b | $1.4b | $1.5b | $1.4b | $1.4b | |
| Interest expense and other | ($278.0m) | ($252.0m) | ($498.0m) | ($1.7b) | ($1.4b) | ($1.2b) | ($1.2b) | ($1.4b) | ($1.4b) | ($1.4b) | $1.4b | |
| Net Investment Income | $1.1b | $1.2b | $1.5b | $1.4b | $1.2b | $1.5b | $1.2b | $1.2b | $973.0m | $1.0b | ($64.0m) | |
| Net gain (loss) on sale of businesses | — | — | $0 | $0 | $4.2b | $0 | $1.7b | ($1.5b) | $24.0m | $13.0m | — | |
| Other Nonoperating Income (Expense) | ($278.0m) | ($252.0m) | ($498.0m) | ($1.7b) | ($1.4b) | ($1.2b) | ($1.2b) | ($1.4b) | ($1.4b) | ($1.4b) | — | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $3.0b | $3.6b | $3.6b | $6.6b | $10.9b | $6.8b | $8.4b | $5.5b | $5.3b | $7.8b | $6.9b | |
| Current Income Tax Expense (Benefit) | — | $1.1b | $1.0b | $1.8b | $2.8b | $1.6b | $2.1b | $1.8b | $1.6b | $1.2b | $1.5b | |
| Income Tax Expense (Benefit) | $1.1b | $1.4b | $935.0m | $1.4b | $2.4b | $1.4b | $1.6b | $141.0m | $1.5b | $1.5b | $1.5b | |
| SHAREHOLDERS' NET INCOME | $1.9b | $2.2b | $2.6b | $5.1b | $8.5b | $5.4b | $6.7b | $5.2b | $3.4b | $6.0b | ||
| Net Income (Loss) Attributable to Parent | $1.8b |
$2.2b
+21.11%
|
$2.6b
+18.55%
|
$5.1b
+93.50%
|
$8.5b
+65.80%
|
$5.4b
-36.21%
|
$6.7b
+24.58%
|
$5.4b
-20.37%
|
$3.8b
-29.67%
|
$6.0b
+57.68%
|
$5.0b
-15.76%
|
|
| Net Income (Loss) Available to Common Stockholders, Basic | $1.8b |
$2.2b
+21.38%
|
$2.6b
+17.88%
|
$5.1b
+93.55%
|
$8.5b
+65.71%
|
$5.4b
-36.57%
|
$6.7b
+24.29%
|
$5.2b
-22.56%
|
$3.4b
-33.50%
|
$6.3b
+83.11%
|
$5.0b
-20.20%
|
|
| Less: Net income attributable to noncontrolling interests | ($24.0m) | ($5.0m) | $9.0m | $16.0m | $31.0m | $50.0m | $78.0m | $208.0m | $344.0m | $331.0m | — | |
| Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest | — | ($5.0m) | $0 | $5.0m | $17.0m | $31.0m | $67.0m | $28.0m | $344.0m | $331.0m | $5.0b | |
| Earnings Per Share, Basic | $7.31 | $8.92 | $10.69 | $13.58 | $23.17 | $15.87 | $21.54 | $17.57 | $12.25 | $22.33 | $24.31 | |
| Earnings Per Share, Diluted | $7.19 | $8.77 | $10.54 | $13.44 | $22.96 | $15.73 | $21.30 | $17.39 | $12.12 | $22.18 | $24.18 | |
| Common Stock, Dividends, Per Share, Declared | $0.00 | $0.00 | $0.00 | $0.04 | $0.04 | $4.00 | $4.48 | $4.92 | $5.60 | $6.04 | — | |
| Weighted Average Number of Shares Outstanding, Diluted | — | 255.1m | 250.2m | 379.8m | 368.4m | 341.0m | 313.1m | 296.9m | 283.2m | 268.6m | 265.3m | |
| Expenses | ||||||||||||
| Debt extinguishment gain | $0 | ($321.0m) | $0 | ($2.0m) | ($199.0m) | ($141.0m) | $0 | $0 | — | — | — | |
| Deferred Policy Acquisition Costs, Amortization Expense | — | $322.0m | $406.0m | $483.0m | $502.0m | $478.0m | $319.0m | — | — | — | — | |
| Medical costs and other benefit expenses | $24.3b | $25.3b | $27.5b | $30.8b | $32.7b | $33.6b | $32.2b | $36.3b | $38.6b | $34.3b | — | |
| Net investment losses | — | — | — | — | — | — | ($487.0m) | ($78.0m) | ($2.7b) | ($24.0m) | — | |
| Pharmacy and other service costs | $2.5b | $2.5b | $4.8b | $97.7b | $103.5b | $117.6b | $124.8b | $133.8b | $182.5b | $215.0b | — | |
| Premiums | $30.8b | $32.5b | $36.1b | $39.7b | $42.6b | $41.2b | $39.9b | $44.2b | $46.0b | $40.3b | — | |
| Benefits, Losses and Expenses | $36.8b | $37.9b | $44.5b | $145.5b | $152.2b | $166.1b | $172.1b | $186.7b | $237.7b | $265.7b | — | |
| Policyholder Benefits and Claims Incurred, Net | $24.3b | $25.3b | $27.5b | $30.8b | $32.7b | $33.6b | $32.2b | $36.3b | $38.6b | $34.3b | — | |
| TOTAL BENEFITS AND EXPENSES | $36.8b | $37.9b | $44.5b | $145.5b | $152.2b | $166.1b | $172.1b | $186.7b | $237.7b | $265.7b |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.